T. Rowe Price Associates’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,997
| Closed | -$55K | – | 2966 |
|
|
2023
Q1 | $55K | Hold |
5,997
| – | – | ﹤0.01% | 2780 |
|
|
2022
Q4 | $70K | Sell |
5,997
-1,713
| -22% | -$20K | ﹤0.01% | 2769 |
|
|
2022
Q3 | $165K | Buy |
7,710
+1,466
| +23% | +$31.4K | ﹤0.01% | 2604 |
|
|
2022
Q2 | $151K | Buy |
6,244
+1,724
| +38% | +$41.7K | ﹤0.01% | 2659 |
|
|
2022
Q1 | $225K | Buy |
4,520
+565
| +14% | +$28.1K | ﹤0.01% | 2663 |
|
|
2021
Q4 | $278K | Buy |
3,955
+253
| +7% | +$17.8K | ﹤0.01% | 2618 |
|
|
2021
Q3 | $345K | Buy |
3,702
+20
| +0.5% | +$1.86K | ﹤0.01% | 2522 |
|
|
2021
Q2 | $370K | Buy |
3,682
+79
| +2% | +$7.94K | ﹤0.01% | 2507 |
|
|
2021
Q1 | $336K | Buy |
3,603
+24
| +0.7% | +$2.24K | ﹤0.01% | 2521 |
|
|
2020
Q4 | $295K | Buy |
3,579
+340
| +10% | +$28K | ﹤0.01% | 2425 |
|
|
2020
Q3 | $278K | Buy |
3,239
+2,827
| +686% | +$243K | ﹤0.01% | 2316 |
|
|
2020
Q2 | $38K | Buy |
412
+59
| +17% | +$5.44K | ﹤0.01% | 2468 |
|
|
2020
Q1 | $10K | Buy |
+353
| New | +$10K | ﹤0.01% | 2497 |
|